372 Preclinical Characterization of RG7256, a Potent and Selective BRAF Inhibitor with Differentiation From Vemurafenib
| Autor: | Su, F., Xu, L., Higgings, B., Yang, H., Packman, K., Hilton, H., Schostack, K., Bollag, G., Tsai, J., Habets, G. |
|---|---|
| Zdroj: | In European Journal of Cancer November 2012 48 Supplement 6:114-114 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect